Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123127) titled 'Study on the efficacy and safety of esmketamine in MECT treatment of depression in adolescents with suicidal ideation or self injurious behavior' on April 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ya'an Fourth People's Hospital
Condition:
depression
Intervention:
control group:Received antidepressants+6 times of conventional MECT (propofol anesthesia)
Recruitment Status: Not Recruiting
Phase: New Treatment Measure Clinical Study
Date of First Enrollment: 2026-05-01
Target Sample Size: control group:30;Test group:30;
Countries of Recruitment:
China
To know more, vi...